Improving STI treatment adherence in adolescents using mobile health
Leveraging Health Information Technology to Reduce Health Disparities in Adolescent Health Outcomes: A Patient-Centered Approach
This study is testing if sending text message reminders can help teenagers stick to their treatment for sexually transmitted infections better than usual care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 270 (estimated) |
| Ages | 15 Years to 21 Years |
| Sex | All |
| Sponsor | Children's National Research Institute Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT04372485 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of two-way text messaging in enhancing adherence to treatment for sexually transmitted infections (STIs) among adolescents. Participants will be randomly assigned to receive either text message reminders or standard care without messaging. The study hypothesizes that those receiving text messages will show a 20% increase in adherence to prescribed antibiotic treatments for conditions like gonorrhea and chlamydia. The trial will take place at Children's National Hospital in Washington, D.C.
Who should consider this trial
Good fit: Ideal candidates are adolescents who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
Not a fit: Patients who are critically ill, have cognitive impairments, or lack access to a cellular phone with text messaging capabilities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and health outcomes for adolescents with STIs.
How similar studies have performed: Previous studies have shown that mobile health interventions can improve treatment adherence in various populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment. Exclusion Criteria: * Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Where this trial is running
Washington D.C., District of Columbia
- Children's National Hospital — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Principal investigator: Monika Goyal — Children's National Research Institute
- Study coordinator: Meleah Boyle, MPH
- Email: mdboyle@childrensnational.org
- Phone: 202-476-5388
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.